IN
InnoCare Pharma Limited
INCPF · OTC
$1.55 +0.00% (+$0.00)
Market Cap ¥15.5B
P/E Ratio 17.09x
Div. Yield -
ROE 12.35%
Bulios Fair Price
$1.14
26.5% downside
Current Price
$1.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, INCPF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
44 /100
Fair EV/EBITDA 12.92x
P/S 5.63x
P/B 2.02x
Growth
84 /100
Growing Book val. growth 0.58%
Rev. growth 54.30%
FCF growth N/A
Profitability
87 /100
Strong Net margin 32.94%
Op. margin 25.90%
FCF margin 8.57%
Quality
47 /100
Average ROE 12.35%
ROA 8.09%
Asset turnover 0.25x
Debt
100 /100
Low Current ratio 4.21x
Int. coverage 13.89x
Net debt/EBITDA -6.29x
Stability
15 /100
Unstable Rev. volatility 58.61%
EPS volatility 118.11%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about INCPF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jisong Cui
Employees
1,259
Headquarters
Beijing
Upcoming events
16 NOV
Earnings
Upcoming earnings report